Monday, October 2, 2023

What's in an asteroid?

Via Ars Technica, this fun news: 
When the spacecraft departed the roughly 1,600-foot-wide (500-meter) asteroid Bennu in 2020, engineers estimated the probe had gathered around 250 grams, or 8.8 ounces, of specimens from Bennu's porous surface. The spacecraft sampled the asteroid by extending a robotic arm out in front of it, then essentially pogoing off the surface, only contacting Bennu for a few seconds. When it touched the asteroid, the spacecraft released a burst of gas to funnel loose rocks into a collection chamber shaped like an air filter on the end of the robot arm. This device is called the Touch-and-Go Sample Acquisition Mechanism, or TAGSAM.

Scientists discovered the collection chamber's door was wedged open with larger rocky material, with some fragments of rock leaking out into space, so they decided to quickly stow the sampling device inside the return capsule to avoid losing more material. That led some scientists on the OSIRIS-REx team to wonder whether the spacecraft might come back to Earth with even more than the 250-gram estimate, which was four times the minimum requirement for mission success.

Researchers likely won't know for sure how much material OSIRIS-REx brought home until next month. That will require the lab team in Houston to remove the TAGSAM sampling mechanism from its restraint inside the canister, which protected it for the journey back to Earth like a nested doll. Then they will open up the device and hopefully find larger chunks of rock. All of this should happen in the next couple of weeks.

There is always that moment when you're taking the flask off the rotovap, or you're taking the lid off the plant sample, and you get this news: 

“We opened up the canister today, and we did see that there is some black dust-like material that's visible," Lauretta said Tuesday. "We're hoping that's from Bennu. We expect that we'll be collecting a portion of that tomorrow morning, and that'll go right into laboratories."

"This is our first glimpse of what we might have," said Lauretta, the OSIRIS-REx mission's principal investigator. "There's good indication that we might have sample." 

Best wishes to the OSIRIS team, and it will be really cool to see what chemicals are a part of asteroids. 

C&EN: California legislature passes bill to ban food chemicals

In this week's C&EN, this news (article by Britt Erickson): 

California is poised to become the first state in the US to ban four chemicals added to processed food. The state legislature passed a bill (AB 418) Sept. 12 that prohibits brominated vegetable oil, potassium bromate, propylparaben, and Red No. 3 dye in food products sold in California, effective Jan. 1, 2027. The legislation now heads to Governor Gavin Newsom, who can sign the bill into law or veto it.

The four ingredients are banned in the European Union and many countries because of concerns about their impact on human health, including cancer, reproductive issues, and behavioral and developmental effects in children.

“This bill will not ban any foods or products—it simply will require food companies to make minor modifications to their recipes and switch to the safer alternative ingredients that they already use in Europe and so many other places around the globe,” the author of the bill, Assembly member Jesse Gabriel, says in a statement.

I can't get very excited about this, but it will be really interesting to see where Red Dye Number 3 is still used. Something tells me that it's not particularly common, but maybe I'm wrong 

Friday, September 29, 2023

Have a good weekend

Well, this wasn't such a bad week, although it certainly had its moments. Here's hoping I get my work done tomorrow. Hope you had a great week, and have a good weekend. See you on Monday! 

The impact of academic mentors, quantified

Via Marginal Revolution, this paper: 
Einstein believed that mentors are especially influential in a protégé’s intellectual development, yet the link between mentorship and protégé success remains a mystery. We marshaled genealogical data on nearly 40,000 scientists who published 1,167,518 papers in biomedicine, chemistry, math, or physics between 1960 and 2017 to investigate the relationship between mentorship and protégé achievement. In our data, we find groupings of mentors with similar records and reputations who attracted protégés of similar talents and expected levels of professional success. 

However, each grouping has an exception: One mentor has an additional hidden capability that can be mentored to their protégés. They display skill in creating and communicating prizewinning research. Because the mentor’s ability for creating and communicating celebrated research existed before the prize’s conferment, protégés of future prizewinning mentors can be uniquely exposed to mentorship for conducting celebrated research. 

Our models explain 34–44% of the variance in protégé success and reveals three main findings. First, mentorship strongly predicts protégé success across diverse disciplines. Mentorship is associated with a 2×-to-4× rise in a protégé’s likelihood of prizewinning, National Academy of Science (NAS) induction, or superstardom relative to matched protégés. Second, mentorship is significantly associated with an increase in the probability of protégés pioneering their own research topics and being midcareer late bloomers. Third, contrary to conventional thought, protégés do not succeed most by following their mentors’ research topics but by studying original topics and coauthoring no more than a small fraction of papers with their mentors.

I think the prizewinning you could probably pin on "who you know" but the original topics bit is very interesting. Cowen asks some interesting questions: "How much of that is mentor value-added, how much that good mentors are amazing talent scouts/magnets, and how much is it that scientists on the rise are very good at mobilizing the highest-value mentors to help them?" I suspect that the middle factor ('they're talent scouts/magnets') is probably the most important aspect.  

Thursday, September 28, 2023

Job posting: senior analytical chemist, Sun Pharmaceuticals, Lexington, MA

Via C&EN Jobs: 
Senior Scientist, Analytical Chemistry, Sun Pharmaceuticals Industries, Inc, Lexington, MA: will ensure that scientific data is of high quality from a technical, accuracy, and GMP compliance perspective. This includes overseeing analytical data generated as part of process characterization, method validation, stability studies and regulatory filings. The role involves collaboration with Concert’s Process Chemistry, Formulation and Quality Assurance groups as well as with our partner contract manufacturing organizations (CMOs) to ensure the accuracy of scientific data. Responsibility is undertaken for the tracking and trending of development and commercial batch data, including yearly product reviews. 

Full ad here. Best wishes to those interested.  

Wednesday, September 27, 2023

FiercePharma: potential drug cross-contamination in Brexafemme API manufacture

Via FiercePharma, this news: 
Monday, Scynexis said in a filing (PDF) that a recent review of the drug's manufacturing process by GSK has triggered a recall of the product and a pause of all clinical trials testing the medicine.  

As part of GSK's review, Scynexis learned of potential cross-contamination risks during the manufacturing process of ibrexafungerp, which is marketed as Brexafemme.

The company is not aware that any of its medicine has been contaminated. Scynexis said it has not received adverse event reports tied to contamination.

Here's the filing: 

Following a recent review by GSK of the manufacturing process and equipment at the vendor that manufactures the ibrexafungerp drug substance, SCYNEXIS became aware that a non-antibacterial beta-lactam drug substance is manufactured using equipment common to the manufacturing process for ibrexafungerp. 

Current FDA guidance recommends segregating the manufacture of beta-lactam compounds from other compounds since beta-lactam compounds have the potential to act as sensitizing agents that may trigger hypersensitivity or an allergic reaction in some people. In the absence of the recommended segregation, there is a risk of cross contamination. 

It is not known whether any ibrexafungerp has been contaminated with a beta-lactam compound and SCYNEXIS has not received reports of adverse events established to be due to the possible beta-lactam cross contamination. Nonetheless, in light of this risk and out of an abundance of caution (and aligned with GSK’s recommendation), SCYNEXIS is recalling BREXAFEMME® (ibrexafungerp tablets) from the market and placing a temporary hold on clinical studies of ibrexafungerp, including the Phase 3 MARIO study, until a mitigation strategy and a resupply plan are determined. 

I genuinely do not understand how someone screwed this one up, but I am going to guess that some QA folks and some manufacturing folks had a very, very bad day. Good luck to the drug substance manufacturer; that's gonna leave a mark.

Job posting: chemical biologist/chemical ecologist, Monell Chemical Senses Center, Philadelphia, PA

From the inbox:
We invite applications for a regular faculty position at all academic levels. The scientist will be expected to launch a laboratory that contributes toward one or more of the Monell strategic research aims (https://monell.org/research/). We desire candidates who combine a fundamental understanding of physiology, immunology, metabolism, or behavior with demonstrated expertise in all facets of quantitative analytical chemistry. We encourage experience at the organismal (e.g. chemical ecology) and/or cellular/molecular (e.g. chemical biology) levels of organization that yield insight into the chemical senses and their roles in chemical communication, nutrition, metabolism, or health.

As principal investigator, the chemical biologist/ecologist will seek external funding and will receive additional support for leading the George Preti Research Support Core for Analytical Chemistry. Approximately 15% effort will be required to direct and expand core capabilities in quantitative analysis. 
Full ad here. Best wishes to those interested. 

Tuesday, September 26, 2023

The 2024 Chemistry Faculty Jobs List: 305 research/teaching positions and 20 teaching positions

 The 2024 Chemistry Faculty Jobs List (curated by Andrew Spaeth and myself) has 305 research/teaching positions and 20 teaching positions . 

Want to help out? Here's a Google Form to enter positions.

To see trending, go to Andrew Spaeth's visualization of previous years' list.

On September 27, 2022, the 2023 Chemistry Faculty Jobs List had 334 research/teaching positions and 20 teaching-focused position.

Want to talk anonymously? Have an update on the status of a job search? Here's the first open thread. 

Don't forget to click on "load more" below the comment box for the full thread. 

“Get a job, Ken!” Part 4: Other Content

This blog posts continues my “Get a Job, Ken!” series. My last post focused on writing research proposals. This post describes the other pieces of my application package. 

There isn’t a standard, one-size-fits-all set of application materials for all faculty job openings, but the majority ask for a cover letter, curriculum vitae (CV) and three letters of recommendation. A few universities also asked for additional items like a teaching statement, a diversity statement, copies of graduate school transcripts, or 4-5 publications.

Cover letter

I personalized the cover letter to each university. Yet, for my own sanity, I reused the same basic cover letter structure: 

Paragraph one: I included a sentence that stated my general area of research. This is important, especially for general call job posts. When search committee chairs or their assistants start organizing applications one of their first goals is to identify the correct person to review it. They—and especially the candidate—want the proposals matched with a reviewer from a similar research domain. Including a sentence that clearly defines your area of research makes the alignment process easier and avoids, for example, having a biochemist assess an inorganic proposal or vice versa.

In the first paragraph I also made sure to note any faculty or consortiums at the institution whose research aligned with mine in ways that could lead to possible collaborations. I included this to demonstrate how I could fit into the departments’ research theme. 

Below is the cover letter I submitted to FSU. 

CV

CVs vary greatly from one person to the next. I don’t know what the ‘right’ CV format is, but in case it’s helpful I am sharing, a copy of my current CV formatting (pdf).

Letters of Recommendation

To help give my references a few months to prepare recommendation letters, I emailed them a few months in advance (July and August). Then, a few weeks before the deadline, I sent a friendly reminder. 

Other Requested Application Materials

Teaching Statement

Half of the openings I applied to asked for a Teaching Statement or, as some describe it, a Statement of Teaching Philosophy. But if we are going to be perfectly honest, teaching statements are much more important when applying to primarily undergraduate institutions. Some of the faculty I met with during interviews said they never saw my teaching statement or new I had submitted one. Regardless, in my teaching statement I mentioned my past experiences and the philosophies that shape my teaching style. While R1 institutions are more interested in research agendas, they are also looking to hire someone to fill any departmental teaching gaps. Acknowledging this, I explicitly listed classes I could teach. That way it is easier for the search committee to see how well I fit their needs. For example, I wrote: 

“Envisioning myself as a future chemistry professor, there are a number of courses that--given the opportunity--I would be very comfortable teaching. These courses include General Chemistry (105a/b, 115a/b), Inorganic Chemistry (453, 515) and Chemical Nanotechnology (455).”

The teaching statement is also an opportunity to share a little bit about who you are as a person. The search committee is not just hiring a scientist and teacher, they’re also looking for a colleague and possible friend. 

Diversity Statement

A diversity statement was only requested by University of California schools and served as an opportunity to express my awareness of and intention to help address the disproportionate involvement of female, African American, Hispanic, and Native American students in science, technology, engineering, and mathematics (STEM) fields. The diversity statement was the space to describe my current efforts to close this gap and how I plan to continue these efforts if hired. 

While a diversity statement is currently only requested by University of California institutions, I would not be surprised if this request soon expands further. Expanding access and representation in STEM fields is a pressing issue. If these inequities are not addressed there will be a serious impact on the number of people prepared to enter STEM fields, especially as the demographics of the United States change. Recognizing this, the NSF has also increased the rigor necessary in the ‘broader impacts’ component of their proposals. It’s no longer acceptable to simply say “I’m going to go to a high school and give a talk” or “I am going to create a new graduate class.” Plans for expanding STEM representation are now expected to be more thought out and impactful and this is especially the case for career awards. 

Rough Budget Proposal

One job application asked us to submit a rough budget proposal. This was a unique request and I am guessing the department had a limited budget and probably couldn’t support a $500,000 piece of equipment. This request, while unusual, seemed completely reasonable since departments want to optimize their time and only invite interviewees whose research they could support. This early request also proved to be a convenience later since I had a rough budget proposal prepared before going into the interviews.

In my next post I’ll talk about the actual application submission process.


The Chemical Engineering Faculty Jobs List: 61 positions

The Chemical Engineering Faculty Jobs List has 61 positions. Find an error or have a question? Find an error? Contact @Heatherlec620 or @G_sribala. 

This is the link to the open thread. 

Monday, September 25, 2023

C&EN: Air Products suing to stop sale of the federal helium system...

Also in this week's C&EN, this fascinating article by Craig Bettenhausen: 
The industrial gas supplier Air Products has filed a lawsuit against the US government seeking to block the ongoing sale of the Federal Helium System. The firm is asking a US District Court for an immediate injunction pausing all proceedings and a set of judgments declaring the sale unlawful as currently structured.

The US Federal Helium System is a set of assets for storing, refining, and distributing helium. It includes a large geological dome formation near Amarillo, Texas; nearly 23 million m 3 of raw helium inside the dome; a set of pipelines that distribute helium to refining sites in Texas, Oklahoma, and Kansas; and supporting equipment and infrastructure. The system, established in the 1920s to fill military dirigibles, currently supplies more than 9% of global helium demand.

The US Congress passed laws in 1996 and 2013 requiring the helium system to be privatized. In response, the government began accepting bids for the system in July of this year. It plans to close bidding on Nov. 15 and sell the system to the winning bidder by mid-March 2024. The legislation requires the government to ensure the stability of helium supplies and markets while disposing of the system.

Air Products cites three main reasons the auction plan sets up any private owner to fail—possibly causing the system to shut down.

One is that the system, especially the pipelines, would struggle to meet state workplace safety, transportation, and environmental standards. The federal government is exempt from state regulations, but a private owner would have to comply. Air Products also says the government lacks complete documentation for several spots where the pipeline runs through private land, “and it takes only one bad right-of-way to shut down the entire pipeline.”

A third complaint is that the sale does not include the crude helium enrichment unit that takes helium out of the dome and prepares it for transfer through the pipelines, nor does it convey to the buyer the operating agreement the government has with the unit’s owner, Cliffside Refiners. Cliffside is a limited partnership consisting of Air Products and the industrial gas firms Praxair, Kinder Morgan, and Messer.
This whole thing is pretty bonkers. I'm genuinely not sure what the right answer is, but it seems to me that having the US government being the guarantor of some portion (9%) of the world's helium supply isn't such a bad thing, especially with the US probably being a reasonably high consumer of helium for both health care and scientific instruments. Here's hoping that someone comes up with a reasonable solution sometime soon...

C&EN: "Lonza’s CEO makes sharp exit"

In this week's C&EN, this surprising news (article by Alex Scott): 

Pierre-Alain Ruffieux, CEO of the contract drug development and manufacturing organization (CDMO) Lonza, will leave “by mutual agreement” at the end of the month, the firm says. He took the role in November 2020. Chairman Albert M. Baehny will become acting CEO until a successor is appointed. Lonza’s next CEO will be its third in four years.

Baehny hints in a press release that the company experienced problems under Ruffieux but that positive times lie ahead. “While recent months have undoubtedly been challenging, the company is a global leader in our industry and has many opportunities for further growth across all our businesses,” he says. The Swiss company’s stock price dropped more than 10% following the news of Ruffieux’s departure.

Jan Ramakers, a consultant to the fine chemical industry, says he sees no obvious reason why the CEO should be leaving. “The contract pharma market has slowed a bit, but still I am surprised at Ruffieux’s departure,” Ramakers says.

This is a bit surprising to me? Here is hoping this news isn't a sign of bad news for pharma services in 2024...

Friday, September 22, 2023

Have a good weekend

Well, this is turning out to be an okay week. Here's hoping it finishes out okay for me, and that it was a decent week for you. A busy weekend ahead - see you on Monday! 

Novo's semaglutide API plant in North Carolina had a 483 in May 2022

Via Reuters, this bit of news: 

LONDON, Sept 21 (Reuters) - U.S. drug regulators issued a report detailing quality control lapses at Novo Nordisk's (NOVOb.CO) main factory in North America as early as May last year, according to the report obtained by Reuters via a Freedom of Information Act request.

The inspection by the U.S. Food and Drug Administration (FDA) was at Novo's facility in Clayton, North Carolina, which the company says produces the active pharmaceutical ingredient (API), semaglutide.

The site makes oral semaglutide for Novo's diabetes drug Rybelsus, a spokesperson told Bloomberg on Thursday. A spokesperson declined to comment when asked by Reuters to confirm this.

Semaglutide is also used in Novo's hugely popular weight-loss drug Wegovy and type 2 diabetes drug Ozempic, which are injections.

There is no evidence that compliance failures flagged in the report known as a Form 483 resulted in harm to users of Wegovy and Ozempic. A Form 483 is a type of agency report containing "observations" that FDA inspectors "deem to be objectionable".

The issues were with the factory's control systems to prevent microbial contamination, the same as those raised in the more recent inspection this July, which was first reported by financial news agency MarketWire and pushed Novo's shares down 3%.

Novo declined to comment on the May 2022 report, which was first reported by Reuters, but repeated its statement on Monday in response to the FDA's report from its July inspection that the Clayton site was "running and producing for the market".

As regular readers know, I am very interested in understanding the supply chain of semaglutide. What is really remarkable to me is that there have been almost immediate shortages from launch. Some of this is clearly demand -  I have long suspected that Novo, being Europeans, did not accurately anticipate either 1) off-label use of Wegovy/Ozempic for weight loss 2) the demand for this in the United States or both. 

I also imagine that a lot of this is about available manufacturing capacity, either for sterile injectables or for API. It seems to me pretty clear that part of the supply problem has been about sterile injectable manufacturing capacity available to Novo. That there may have also been a crimp in API supply in May 2022 might add another piece of the puzzle as well. 

Thursday, September 21, 2023

Job posting: Senior Chemist, Engineered Custom Coatings, Pewaukee, WI

Via C&EN Jobs, this posting: 

Duties

  • Develops new methods to simplify manufacturing methods for specific lines. 
  • Develops methods to update existing formulas and directs technicians on methods. 
  • Assesses and creates formulas and applies them to varies customer substrates and materials. 
  • Accurately formulates color matches via water-based and UV paints for customers, adjusting formulas based on pigments and available products. 
  • Develops formulations to meet customer requirements and consult leadership on viable options. 
  • Effectively communicates with suppliers to understand the makeup of their materials. 
  • Tests formulas and applies materials to measure quality under a variety of environmental conditions against various performance goals. 
  • Perform bonding tests on materials such as cotton, polyester, blend, silks, plastics, PP, PET, PTFE, leather, etc. 
  • Compiles test results and analyze patterns through the data to place the product into the trial phase.
Full ad here. Best wishes to those interested. 

Wednesday, September 20, 2023

Are there fewer faculty applicants this fall?

Via the open thread from the Faculty Jobs List, this question: 

Has anyone gotten the sense that there are fewer candidates on the market this year? I've heard from a couple schools that they are getting way fewer applications than expected.

I would like to hear from search committee members, either in the comments or via email. I'm happy to provide confidentiality if desired. 

NYT: art conservators discovered the cause of fading yellows in painting

Via the New York Times: 

From Van Gogh’s sunflowers to Edvard Munch’s “The Scream,” there’s no shortage of seminal artwork that was made with a striking hue known as cadmium yellow. But that riot of color that artists squeezed from their paint tubes isn’t necessarily what museum goers see today: cadmium yellow’s brilliance often diminishes over time, as the paint fades and turns chalky.

And it’s not only centuries-old artworks that are affected. A team of art conservators and scientists recently analyzed bits of degraded cadmium yellow paint taken from pieces painted by the Spanish artist Joan Miró in the 1970s. One particular brand of paint was likely most responsible for the degradation observed in the Miró pieces, the team concluded in a study published in July in the journal Heritage Science.

...Furthermore those six samples — from the degraded paintings, the palettes and the tube of Cadmium Yellow Lemon No.1 by Lucien Lefebvre-Foinet — all exhibited poor crystallinity, the team found. That means that the cadmium and sulfur atoms aren’t perfectly interlocked in their usual hexagonal arrangement, said Daniela Comelli, a materials scientist at the Polytechnic University of Milan and a member of the research team. “There’s some disorder.”

If you click through to the research article, looks like (unsurprisingly) the sulfur is getting oxidized. I'm just imagining a worker making a random change many years ago that resulted in this lessened crystallinity...

Tuesday, September 19, 2023

The 2024 Chemistry Faculty Jobs List: 265 research/teaching positions and 17 teaching positions

The 2024 Chemistry Faculty Jobs List (curated by Andrew Spaeth and myself) has 265 research/teaching positions and 17 teaching positions . 

Want to help out? Here's a Google Form to enter positions.

To see trending, go to Andrew Spaeth's visualization of previous years' list.

On September 20, 2022, the 2023 Chemistry Faculty Jobs List had 294 research/teaching positions and 15 teaching-focused position.

Want to talk anonymously? Have an update on the status of a job search? Here's the first open thread. 

Don't forget to click on "load more" below the comment box for the full thread. 

“Get a job, Ken!” Part 3: Proposal Format

Continuing my “Get a job, Ken!” series, this post builds upon the last post by suggesting how to turn research ideas into written proposals.

Strong proposals contain a competitive research idea (as discussed in my previous post), clearly communicate the idea, and concisely propose a plan to pursue it. The plan being the materials, measurements, expected results, and potential complications you may run into while attempting to turn the never-before-implemented idea into something real. Finally, strong proposals sell the idea by explaining why it’s unique, scientifically significant, and attractive to funding agencies. 

A large majority of job openings do not specify a page limit for the proposal component, but I followed the advice of several friends and Professors to keep it at or under 10 pages. In these ten pages I included a cover page, three proposals (at three pages each), and one page of references. Below I break down each of these sections in greater detail.

The Cover Page

The search committee members will be bombarded with hundreds of applications. They simply will not have time to read through a three, let alone ten, page proposals from every applicant. I’ve heard from a few professors that they do not look at CVs or recommendation letters until the candidate list is whittled down based on the first page of the proposal alone. The cover page may be the deciding factor between making it through the first round or being cut. This is why it’s very important to spend a lot of time making a clear and compelling cover page.

The general format I used for my cover page can be seen in the image below. Forgive me for not sharing my actual proposal cover page. I haven’t had the opportunity to pursue the ideas yet.

As shown in the image, my cover page included: 

  • My name and contact information at the top of the page.
  • A Research Overview, explaining my flavor of research and what I’ll be known for in five years if given the chance to pursue my proposals. 
  • A subsection for each proposal that included: 
  1. A title 
  2. Page numbers
  3. A brief summary, which was structured similar to an abstract. It introduced a problem to be solved, how I intend to solve it, and the potential implications.
  4. A pretty image depicting the research idea. 

The images accompanying each proposal might be the most important part of the cover page. They should be descriptive, aesthetically pleasing, and eye catching. The goal is to get the search committee curious enough about the ideas so they will look through the proposals and other application materials. 

The Proposals

Each proposal should be three pages or less. Since the faculty search committee may include a broad range of chemists, you should try to limit the use of jargon and not assume too much prior knowledge about your research area. Compressing this information into three pages or less sounds like a monumental task and, to be perfectly honest, it is. It will take a lot of time and effort to put a short but solid proposal together. In an effort to help, below is a generic form of my proposal format.

As shown in the image, each of my proposals were organized into the following three sections: 

Section one: Background and Significance

  • Introduce a problem that needs to be solved.
  • Describe how others are trying to solve it.
  • Describe how I am going to try to solve it.
  • Discuss how my method is better.

In this section, I included one bold sentence that clearly summarized the nature of my proposal and an italicized sentence outlining a few specific goals. 

Section Two: Plan of Work

  • Explain the logistics of how you’ll pursue your idea (i.e. the materials, measurements, expected results, and potential complications).

Section Three: Impact and Funding

  • Remark on the potential implications of the proposed work. 
  • List a few potential funding agencies. 

When mentioning funding agencies be very explicit. Include the agencies (NSF, NIF, DOE, ARO, etc.) as well as the divisions and sub-divisions within the agencies. An easy way to find possible funding agencies is to look at the acknowledgements section of the papers cited in your proposal. Chances are you will be applying to the same funding opportunities. 

Example: "The importance of solar energy conversion research in our current economic and political climate leads me to believe my research program will appeal to both students and funding agencies like the National Science Foundation (CHE/MSN, DMR/SSMC) and Department of Energy (BES/MSE, CSGB)."

Citations

I made sure to fit all of my citations on one final page to keep the total page count at 10. As far as citation format, I went with ACS standard formatting but others might work just as well.

Other Formatting Notes

Although some people choose a one-column format, I decided to go with two columns because it is more analogous to many journal articles and, for me, feels easier to digest. I also made sure to include at least one pretty picture per page. It breaks up the wall of text. 

Proofreading

I started drafting my proposals early (June or July) so I had time to play around with and re-write the text many times. Maybe more importantly, the time also allowed others to proofread what I’d written. Our aspiring professor support group (described in “Get a job, Ken!” Part 2) was particularly useful for proofreading.  We set up an editing rotation: I shared each of my proposals with three different people for feedback. I also read nine proposals from six different people.

After the aspiring professor support group’s initial screening and revisions, I also asked for comments/suggestions from several professors who had either been on a hiring committee before or just went through the job application process. This included my previous advisors and several Profs. at UNC. They were a big help because they let me know what they found compelling and memorable as well as where I could improve. Finally, I turned outside of the chemistry world to people like my wife to proofread for language and spelling errors. 

In the next blog post I’ll share a similar breakdown for the other application materials.

The Chemical Engineering Faculty Jobs List: 55 positions

The Chemical Engineering Faculty Jobs List has 55 positions. Find an error or have a question? Find an error? Contact @Heatherlec620 or @G_sribala. 

This is the link to the open thread. 

Monday, September 18, 2023

C&EN: Downbeat outlook at ChemOutsourcing

Via Rick Mullin at Chemical and Engineering News:

...But at ChemOutsourcing, a smaller meeting of pharmaceutical services firms in New Jersey earlier this month, there was far less focus on AI and a more dour outlook for the business of manufacturing pharmaceutical ingredients for drug companies.

Price pressures, a prolonged dip in biotech stock prices, and general hesitancy on the part of venture capital firms to invest in small and mid-sized drug companies foreshadow a slowdown in contract manufacturing next year, many in attendance said.

“I think 2024 is going to be a bit of a transitional year,” predicted Kenneth Drew, vice president of US operations for the Italian services firm Flamma. A downturn would follow a decade of double-digit annual growth for many services companies in a sector that thrived during the pandemic.

With financing tight, biotech firms are now often focused on only their lead drug candidate, a strategy that Drew likened to keeping all eggs in one basket. “If that basket breaks, it can kill a company,” he said, a development that would reverberate at Flamma and other companies that serve such firms.

But Stefan Loren, managing director for healthcare investment banking at Oppenheimer, said in a keynote address at ChemOutsourcing that the disappearance of a few small to mid-sized biotech companies may not be a bad thing for the sector. He noted that the number of publicly traded biotechs has risen from 125 in 2012 to 706 in 2023, diluting the availability of investment capital.

“Biotechs have to fold, go bankrupt, or be swallowed up” through mergers and acquisitions, Loren said, noting that generalist investors are not currently investing in small companies. Such culling could combine with a drop in inflation to fuel a biotech recovery going into next year, Loren said.

James Bruno, president of the consulting firm Chemical and Pharmaceutical Solutions, cautioned that a brighter 2024 may not be within reach for services firms. “The financial markets are opening up, but I don’t think small pharma actually sees that yet,” he said, and that doesn’t bode well for services firms.

It will be interesting to see if this is the case. If there is a slowdown in services firms, you could imagine a slowdown in the hiring at the Curias and Cambrexes of the world... 

Friday, September 15, 2023

Have a good weekend

This has been an interesting week, but not an entirely bad one. I hope that you had a good week, and that you have a great weekend. We'll see you on Monday. 

Science Magazine: Cheeky Scientist Targets Students and Postdocs for High-Interest Loans

An important article by Catherine Offord of Science: 
When Sara saw a LinkedIn ad earlier this year for a company promising to help science, technology, engineering, and math (STEM) Ph.D.s transition into lucrative industry careers, she thought she had nothing to lose by finding out more. With her postdoc coming to an end and her efforts to find a job and secure financial stability falling short, she was feeling desperate, she says. So she agreed to an introductory video call with a “transition specialist” at Cheeky Scientist, which bills itself on its website as the “world’s premier career training platform for PhDs” and claims to have helped “thousands of PhDs” move from academia to industry.

Sara describes what transpired as an aggressive sales pitch that played heavily on her anxiety about unemployment. The representative made her an offer: Cheeky Scientist’s Diamond Program, an online mentoring package, for a little over half what he said was the standard retail price of $9998—provided she sign up immediately. He had a solution for financing, too: a high-interest loan he could help her apply for through another company, there and then. Under pressure, Sara says, she signed up, but regretted it as soon as she was off the call. She contacted Cheeky Scientist within hours to request a cancellation. Now, she’s saddled with thousands of dollars of debt and is no closer to reclaiming her money—despite not using the company’s services.

I've long been skeptical of Cheeky Scientist's practices, and this seals it for me. Their practices are untrustworthy, and this organization should be stopped wherever possible. 

If you are a professor who reads this blog, I respectfully ask that you speak with your career services people to ask that your institution not work with Cheeky Scientist. There are plenty of free career resources for early-career researchers in science, and if you cannot find ones that you like, I will help you try to find them. Let's help make the science community a better place, and drive predators like Cheeky Scientist away. 

Thursday, September 14, 2023

Job posting: special projects chemist, Marathon Petroleum, Catlettsburg, KY

Via C&EN Jobs: 

Marathon Petroleum Company, the largest petroleum refiner in the United States, is seeking an experienced Chemist for its Refining Analytical and Development (RAD) Department in Catlettsburg, Kentucky.  The individual selected for this position will leverage their chemistry knowledge to investigate multiple topics in support of petroleum and sustainable fuels production and for the MPC fuels’ distribution systems including pipelines, terminals, and retail. Areas of support could include but are not limited to feedstock/fuel improvements through additives/process change identification, examining corrosion/deposition for mechanism deduction, test methods development, and new instrument evaluations.  Involvement in industry organizations like API, ASTM, and CRC is likely. 

KEY RESPONSIBILITIES

  • Become a technical advisor for the company on chemical processes in the petroleum- and bio-refining areas.
  • Apply refining process operations knowledge in the coordination of testing materials and the interpretation of analytical results to elucidate fouling/corrosion mechanisms.

EDUCATION AND EXPERIENCE

  • Bachelor's degree in Chemistry or other related discipline is required.
  • Doctorate in Chemistry or other related discipline is preferred.
  • Five years experience in the petroleum industry is preferred.
Full ad here. Best wishes to those interested. 

Wednesday, September 13, 2023

Explosion and fire at Decatur ADM plant on Sunday

Via Reuters, this news: 

CHICAGO, Sept 11 (Reuters) - Several employees were hospitalized after an explosion and fire late on Sunday at a massive Archer-Daniels-Midland (ADM) facility in Decatur, Illinois, that severely damaged crop processing operations, the company and the local fire department said.

Eight workers were injured at the ADM East processing plant and six were taken to hospital via ambulance, the Decatur Fire Department said in a statement on Monday. Five remained hospitalized on Monday morning, ADM said.

The company said it was evaluating the extent of the damage and investigating the cause of the incident.

Several structures were severely damaged in the blast, including a 10-story building and adjacent buildings, the fire department said.

A plant that crushes soybeans into soybean oil and white flake for soy protein production was down on Monday, ADM said. An adjacent corn processing plant was also "temporarily down until we can safely resume operations," the company said.

Best wishes to their friends and family of the victims. I'm terribly curious as to what happened (i.e. what could have caused the explosion), but I am going to guess that the soybean oil is extraed with some kind of solvent? Maybe it was hydrogenation-related? (ADM does hydrogenation but does it do it in Decatur?) Guess I'll have to keep track of this.